Dental Care Clinics in Murray, KY Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 Arnett Dental Care Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1405 Dudley Dr, Murray, KY 42071 Phone: 270-753-6327 Fax: 270-753-6386 |
Ky Tn Oral Surgery Pllc Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 1109 Poplar St, Murray, KY 42071 Phone: 270-759-4063 Fax: 270-759-4920 |
Elevation Dentistry Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1710 Hwy 121 N. Byp. Ste A, Murray, KY 42071 Phone: 270-753-9479 Fax: 270-761-2528 |
Taylor Family Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 700 Whitnell St, Murray, KY 42071 Phone: 270-753-9201 Fax: 270-753-4268 |
Michael L Bobo Dds Md Psc Dentist - Oral and Maxillofacial Surgery Medicare: Medicare Enrolled Practice Location: 1109 Poplar St, Murray, KY 42071 Phone: 270-759-4063 Fax: 270-759-4920 |
News Archive
Heart attack patients with bypass history more likely to have delayed treatment
Heart attack patients who had previously undergone cardiac bypass surgery are about twice as likely to have a delay in receiving angioplasty, or another form of revascularization, compared to heart attack patients who had no history of bypass surgery or previous angioplasty.
Managing fluid volume and salt losses during a marathon may help avoid post-race kidney injury
Legend states that after the Greek army defeated the invading Persian forces near the city of Marathon in 490 B.C.E., the courier Pheidippides ran to Athens to report the victory and then immediately dropped dead.
CVS Caremark announces third quarter revenues, operating profit and net income
CVS Caremark Corporation today announced record third quarter revenues, operating profit, and net income for the quarter ended September 30, 2009.
Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
Class-action lawsuit seeks to let Medicare patients appeal gap in nursing home coverage
Medicare paid for Betty Gordon's knee replacement surgery in March, but the 72-year-old former high school teacher needed a nursing home stay and care at home to recover.
› Verified 7 days ago